[1] DURDU M, KANDEMIR H, ILKIT M, et al. Changing concepts and current definition of Majocchi's granuloma[J]. Mycopathologia, 2020, 185(1):187-192. [2] BONIFAZ A, TIRADO-SÁNCHEZ A, MERCADILLO P, et al. Clinical and mycological study of 42 cases of dermatophytic granuloma (Majocchi granuloma)[J]. J Dtsch Dermatol Ges,2021,19(5):758-761. [3] BORAL H, DURDU M, ILKIT M. Majocchi's granuloma:current perspectives[J]. Infect Drug Resist,2018,22(11):751-760. [4] ABDELAAL NH, RASHED L A, IBRAHIM S Y, et al. Cathelicidin (LL-37) level in the scalp hair of patients with tinea capitis[J]. Med Mycol,2017,55(7):733-736. [5] VAN KILSDONK J W J, JANSEN P A M, VAN DEN BOGAARD E H, et al. The effects of human beta-defensins on skin cells in vitro[J]. Dermatology,2017,233(2-3):155-163. [6] ILKIT M, DURDU M, KARAKAŞ M. Majocchi's granuloma:a symptom complex caused by fungal pathogens[J]. Med Mycol,2012,50(5):449-457. [7] SEKIGUCHI K, NISHIYAMA C, YOSHIIKE T, et al. The relation between the growth and extracellular proteolytic activity in Trichophyton rubrum, comparing isolates from granuloma trichophyticum with tinea superficialis[J]. Nihon Hifuka Gakkai Zasshi,1989,99(10):1117-1119. [8] NENOFF P, KRVGER C, SCHALLER J, et al. Mycology-an update part 2:dermatomycoses:clinical picture and diagnostics[J]. J Dtsch Dermatol Ges,2014,12(9):749-777. [9] GUPTA A K, KOHLI Y, BATRA R. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species[J]. Med Mycol,2005,43(2):179-185. [10] RALLIS E, KATOULIS A, RIGOPOULOS D. Pubic Majocchi's granuloma unresponsive to itraconazole successfully treated with oral terbinafine[J]. Skin Appendage Disord,2016,1(3):111-113. |